Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma [Phase 2]
This report describes a Phase 2 trial of the radioimmunotherapy combination Tositumomab with Iodine-131 for previously untreated, advanced-s…
-
FDA approval · 2012-06-26FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) submitted by Cephalon, LLC.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating peripheral stem cell transplantation after radiation therapy has completed in patients with Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This is a completed Phase 1/Phase 2 trial evaluating chemotherapy and radiation therapy with bone marrow or peripheral stem cell transplanta…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This clinical trial update reports the completed Phase 1/2 study of IDEC-114 in Non-Hodgkin lymphoma, assessing safety and efficacy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL [Phase 1]
Phase 1 trial of 90Y-ibritumomab tiuxetan with high-dose chemotherapy and autologous transplantation in relapsed or resistant non-Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study evaluating the combination of ifosfamide, teniposide, and paclitaxel in patien…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 study evaluated radiolabeled monoclonal antibody therapy followed by high-dose chemotherapy and autologous stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluated peripheral stem cell transplantation to prevent neutropenia in patients with relapsed or refractory non-Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of Lmp1 and Lmp2-specific cytotoxic T lymphocytes following CD45 antibody for relapsed EBV-positive Hodgkin lymphoma or non-Ho…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating the combination of chemotherapy with peripheral stem cell transplantation for newly diagnosed aggressive non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma [NA]
A completed Stanford University clinical trial evaluating enrichment and purging of stem cells in non-Hodgkin lymphoma.
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Palifermin After Haploidentical PBSCT [Phase 2]
A Phase 2 trial evaluating palifermin after haploidentical peripheral blood stem cell transplantation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Prevention of CHOP-induced Chronic Cardiotoxicity [Phase 4]
Phase 4 trial update focusing on preventing chronic cardiotoxicity from CHOP chemotherapy in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies [Phase 1]
A Phase 1 study evaluating SB1518 in patients with advanced lymphoid malignancies (Hodgkin lymphoma and non-Hodgkin lymphoma) has been compl…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies [Phase 2]
Phase 2 dosimetry/validation study of 131Iodine-Anti B1 (murine) radioimmunotherapy in chemotherapy-refractory low-grade B-cell lymphomas, i…
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 pivotal study results for iodine-131 tositumomab in chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating a multi-agent chemotherapy regimen with rituximab and Y-90 ibritumomab tiuxetan followed by radiotherapy in early-s…
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update evaluating the safety and preliminary efficacy of the radiolabeled anti-B1 monoclonal antibody (Coulter Clone 131Iodine…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) [Phase 2]
A Phase 2 study of oral panobinostat (LBH589) in relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma has been termi…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after periph…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab [Phase 2]
Phase 2 study evaluating the safety and efficacy of three cycles of fludarabine followed by tositumomab and iodine-131 tositumomab in Non-Ho…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rasburicase for treatment/prevention of hyperuricemia in adults with relapsing aggressive non-Hodgkin lymphoma; sta…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. [Phase 1]
This document reports the results of a Phase 1 bioequivalence study of Vinorelbine tartrate injectable emulsion in patients with advanced ca…
-
CLINICAL_TRIALS withdrawal · 2012-02-23Clinical Trial Update: Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy [Phase 1]
Phase 1 safety study of a PD-L1 inhibitor sponsored by Bristol-Myers Squibb has been withdrawn. The study targeted hematologic malignancies …